Neogen Corporation

NEOG

$11.73

+0.73%

2026-09-04 13:07:25 EDT+$0.08

Healthcare

Medical - Devices

NASDAQ

Negociación activa

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for ...

Evolución del precio de NEOG

$11.73

+0.73%+$0.08

Máximo—

Mínimo—

Máx. 52s-8.8%

Vol. rel.—

Intervalo

Rango2.9h

Volumen—SMA5SMA10

—

Neogen Corporation, founded in 1982 by Herbert Dow Doan and James L. Herbert, is a public company listed on NASDAQ (Symbol: NEOG) and operates in the Healthcare sector, specifically in Medical - Diagnostics & Research. The company is dedicated to creating, manufacturing, and distributing products that ensure food quality and ...Neogen Corporation, founded in 1982 by Herbert Dow Doan and James L. Herbert, is a public company listed on NASDAQ (Symbol: NEOG) and operates in the Healthcare sector, specifically in Medical - Diagnostics & Research. The company is dedicated to creating, manufacturing, and distributing products that ensure food quality and animal health worldwide. It operates through two primary divisions: Food Safety and Animal Safety. The Food Safety segment offers advanced diagnostic test kits and solutions to identify harmful contaminants in food and animal feed, including foodborne pathogens, spoilage organisms, toxins, allergens, genetically modified ingredients, and drug residues. Notable products include the AccuPoint Advanced rapid sanitation test for detecting ATP to verify cleanliness. Customers range from food producers and processors to laboratories and pharmaceutical companies. The Animal Safety division provides a comprehensive portfolio for animal health, including veterinary instruments, pharmaceuticals, vaccines, diagnostics, and genomics services. This segment also plays a role in detecting illicit drugs in animals and assisting in forensic toxicology. Neogen serves a global market with a significant presence in over 100 countries. The company is led by CEO Mike Nassif, who brings over two decades of global leadership experience. Financially, Neogen has a market cap of approximately $2.5 billion, with a recent stock price of $11.47. The company employs around 2,636 full-time employees. Despite a slight negative net profit margin TTM, Neogen maintains a strong gross profit margin of 46.9% and an EBITDA margin of 19.8%. The company invests in research and development (2.1% of revenue) and has a solid current ratio of 3.82, indicating good short-term liquidity. Neogen is committed to global food security and advancing human and animal well-being, with a long history of innovation from its roots at Michigan State University.ExpandirContraer

Fundación

1982

Empleados

2636

CEO

Mikhael Nassif

Nombre completo

Neogen Corporation

Sector

Healthcare

Industria

Medical - Devices

ROE

-0.37%

Capitalización

$2.56B

Ratio corriente

3.82

WACC

11.32%

ROIC

1.33%

Información de contacto

https://www.neogen.com

517 372 9200

620 Lesher Place, Lansing, MI 48912-1595

Métricas clave de NEOG

Instantánea

Último / TTM · 6 periodos

Capitalización

$2.56B

ROCE

-0.7%

EV / EBITDA

18.45x

-0.0% YoY

Rendimiento FCF

1.2%

-0.4% YoY

Ciclo de conversión de efectivo

113.1d

Ratio corriente

3.82

Resumen rápido

TTM —

Positive CCC

Aspectos financieros de NEOG

Tendencia de rentabilidad

Último / TTM · 6 periodos

Margen bruto

46.9%

Margen neto

-0.9%

PER

-354.57x

n/d

Deuda / capital

0.38

n/d

Ratio corriente

3.82

Rendimiento del dividendo

0.0%

Comprensión

TTM —

La cobertura de intereses es débil

Calendario de NEOG

Próximamente

8 oct 2026En 34 días
Q1 FY2027 · Publicación de resultados
BPA est. $0.04
28 feb 2027
Q3 FY2027 · Resultados estimados
BPA est. $0.07 · Ingresos $215.88M · 1 analistas
31 may 2027
FY2027 · Resultados anuales estimados
BPA est. $0.31 · Ingresos $879.92M · 3 analistas
31 ago 2027
Q1 FY2028 · Resultados estimados
BPA est. $-0.04 · Ingresos $192.60M · 1 analistas

Historial reciente

30 jul 2026
FY2026 · Resultados anuales
BPA $-0.04 · Ingresos $870.40M
Ver documento
9 abr 2026
Q3 FY2026 · Resultados publicados
BPA $-0.08 · Ingresos $211.20M
Ver documento
8 ene 2026
Q2 FY2026 · Resultados publicados
BPA $-0.07 · Ingresos $224.69M
Ver documento
9 oct 2025
Q1 FY2026 · Resultados publicados
BPA $0.17 · Ingresos $209.19M
Ver documento
30 jul 2025
FY2025 · Resultados anuales
BPA $-5.03 · Ingresos $894.66M
Ver documento
9 abr 2025
Q3 FY2025 · Resultados publicados
BPA $-0.05 · Ingresos $220.98M
Ver documento

Estados financieros de NEOG

Próxima fecha de resultados

Oct 8, 2026

Estimación de EPS 0.04 · Fin del periodo fiscal 2026-08-31

D-34

Tendencia de 5 años (ingresos, beneficios, FCF)

Métrica	Último	InteranualYoY significa Year-over-Year (interanual). Compara el último valor anual con el valor anual anterior para mostrar la fortaleza de la tendencia a largo plazo.	TrimestralQoQ significa Quarter-over-Quarter (intertrimestral). Compara el último trimestre con el trimestre inmediatamente anterior para mostrar cambios de impulso a corto plazo.
IngresosEl dinero total que entró por la puerta principal al vender cosas, antes de pagar una sola factura. Piensa en esto como el gran total de cada compra con tarjeta de los clientes. (YoY compara el rendimiento de este año con el del año pasado, mientras que QoQ compara los tres meses actuales con los tres anteriores).	$870.4M	-2.7%	+6.7%
Beneficio netoEl resultado final absoluto. Si la empresa pagara a cada proveedor, empleado, banquero y recaudador de impuestos, este es el dinero real que queda en su bolsillo al final del día.	$-7.9M	+99.3%	+33.5%
Margen brutoEl margen básico. Si venden unas zapatillas de 100 dólares, este porcentaje indica cuánto de ese precio es ganancia justo después de pagar el caucho y los cordones, pero antes de pagar el alquiler de la tienda o los anuncios de televisión.	+46.9%	-0.4%	+2.1%
Margen operativoLa puntuación de eficiencia del 'trabajo diario'. De cada dólar que gasta un cliente, esto muestra cuántos centavos mantiene la empresa después de fabricar el producto Y pagar todos los gastos generales corporativos (como salarios, marketing y mantener las luces encendidas).	-2.5%	-335.7%	+188.1%
Margen netoEl porcentaje final que se lleva a casa. Cuando se eliminan todos los costos concebibles, impuestos y pagos de intereses, este es el número exacto de centavos que la empresa realmente se queda de cada dólar en ventas.	-0.9%	+99.3%	+37.7%
Flujo de caja libreEl santo grial del efectivo corporativo. Es el dinero físico gastable que queda después de que el negocio paga sus operaciones diarias Y compra las actualizaciones grandes y costosas (como nuevas fábricas o servidores) que necesita para sobrevivir. Este es el dinero 'libre' que pueden usar para pagar dividendos o recomprar acciones.	$31.9M	+168.8%	-185.5%
Margen FCFLa tasa definitiva de conversión de efectivo. Muestra qué tan buena es la empresa para convertir ventas regulares directamente en efectivo frío, duro y gastable. Un porcentaje alto significa que el negocio es una auténtica máquina de imprimir dinero.	+3.7%	+170.7%	-180.2%
Deuda/PatrimonioEl indicador de riesgo financiero. Compara cuánto del imperio de la empresa se construyó con dinero prestado (préstamos) frente al dinero propio de los propietarios (accionistas). Un número alto significa que están muy apalancados y juegan un juego más arriesgado; un número bajo significa que juegan a lo seguro.	37.9%	-13.9%	+0.5%
Ratio corrienteLa verificación de supervivencia de 12 meses. Simplemente compara el efectivo que tienen ahora mismo (más cosas que pueden convertirse rápidamente en efectivo) con las facturas inmediatas que absolutamente deben pagar este año. Una puntuación superior a 1 significa que tienen suficiente en la billetera para cubrir las próximas facturas sin entrar en pánico.	3.82x	+15.3%	-2.4%
Activos totalesEl tamaño absoluto del imperio de la empresa. Agrupa absolutamente todo lo valioso que poseen, desde el efectivo en la caja registradora y el inventario en el almacén, hasta las patentes de software en la bóveda y las fábricas en el suelo.	$3.3B	-2.8%	-0.4%

Real vs estimado

A May 31Q Feb 28

Métrica	Anual (real vs estimado)	Sorpresa anual	Trimestral (real vs estimado)	Sorpresa trimestral
EPS Surprise	-0.04 vs 0.29	-114.0%	-0.05 vs 0.07	-175.0%
Revenue Surprise	$870.4M vs $857.5M	+1.5%	$225.3M vs $215.9M	+4.4%

Transacciones de insiders de NEOG

Compras (A)

Since Aug 14, 2026

Ventas (D)

Since Aug 14, 2026

Acciones mensuales compradas/vendidas con tendencia del precio de cierre (fuente diaria compartida)

Resumen de trading de insiders

Fecha	Ejecutivo	Cargo	Valor	Lado	Acciones	Precio
Aug 19, 2026	Moylan John Patrick	officer: Chief Accounting Officer	Restricted Stock Units	D	2,365	$11.87
Aug 19, 2026	Nassif Mikheal	director, officer: CEO	Restricted Stock Units	D	20,397	$11.87
Aug 14, 2026	Moylan John Patrick	officer: Chief Accounting Officer	Restricted Stock Units	A	8,584	$11.65
Aug 14, 2026	Moylan John Patrick	officer: Chief Accounting Officer	Common Stock (Right to Buy)	A	18,693	$11.65
Aug 14, 2026	Ranalli Tamara A.	officer: Senior Vice President	Common Stock (Right to Buy)	A	130,851	$11.65

Transcripción de la llamada de resultados de NEOG

1 segmentos de transcripción

Q4 2026

Ponente desconocido

Operator : Hello, everyone. Thank you for joining us, and welcome to the Neogen 4Q '26 Earnings Call. I will now hand the conference over to Scott Gleason. Scott, please go ahead. Scott Gleason : Thank you for joining us this morning to discuss our fiscal fourth quarter and full year 2026 results. I will briefly cover our non-GAAP and forward-looking disclosures before turning the call over to our CEO, Mike Nassif; our CFO, Bryan Riggsbee; and our CCO, Joe Freels. Earlier this morning, we issued our fourth quarter and full year results and accompanying presentation, both of which are available on the Investor Relations section of our website. During today's call, we will reference certain non-GAAP financial measures that we believe provide useful insight into our performance. Reconciliations of historical non-GAAP measures are included in our earnings release and presentation. Please also refer to Slide 2 of the presentation, which contains reminders regarding forward-looking statements under the Private Securities Litigation Reform Act. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. These risks are described in our most recent annual report on Form 10-K and in other filings with the SEC. We undertake no obligation to update these forward-looking statements. With that, I'm pleased to turn the call over to Mike. Mikhael Nassif : Thank you, Scott. Good morning, and thank you for joining us. We operate in a highly attractive market, supported by strong growth drivers. Customers increasingly require a true industry leader who can innovate and solve complex challenges. Food safety and security are critical and growing global priorities, and we believe Neogen is uniquely positioned to lead this industry. We closed fiscal year '26 on a strong note. Core growth improved sequentially across both our Food Safety and Animal Safety business units in the fourth quarter. Our fiscal 2027 financial guidance reflects a measured outlook consistent with our historical approach. While my confidence in the trajectory of our business entering the year is high, we believe our macro fundamental backdrop is improving. We have restored our product portfolio and significant progress is underway in enhancing our commercial operations. We exceeded our adjusted EBITDA guidance for the year. At the same time, we are intentionally investing in Neogen's future, and this will remain a key theme through fiscal year 2027. We're funding innovation, technology solutions, enterprise systems and marketing capabilities that are designed to meaningfully enhance the company's long-term growth trajectory. We're prioritizing these investments to position Neogen to win while also driving profitable growth. I would also highlight that Food Safety core growth reached 5.8% in the quarter, the highest level since 2023, going back to the period immediately following the 3M acquisition. In addition, …

Equipo directivo de NEOG

10 directivos

Nombre	Cargo	Remuneración	Género	Año de nacimiento	Estado
Mikhael Nassif	Chief Executive Officer, President & Director	USD 2,193,915	Male	—	Active
R. Bryan Riggsbee	Chief Financial Officer & Senior Vice President	USD 1,089,052	Male	1970	Active
Tamara A. Ranalli	Senior VP & GM of Global Food Safety	USD 648,850	—	1974	Active
Jeremy Yarwood	Chief Scientific Officer	USD 476,992	—	—	Active
Jennifer Evans Stacey	Chief Legal & Compliance Officer and Board Secretary	USD 434,186	Female	1965	Active
Kevin Burke	Chief Human Resources Officer	—	Male	1969	Active
Bill Waelke	Head of Investor Relations	—	Male	—	Active
Joe Freels	Senior VP & Chief Commercial Officer	—	Male	—	Active
John Moylan	Vice President, Corporate Controller & Chief Accounting Officer	—	Male	—	Active
Sarah Demey	Administrative Manager	—	—	—	Active

Noticias recientes de NEOG

Seeking Alpha30/7/2026Neutral

Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript

Zacks Investment Research30/7/2026Neutral

Neogen (NEOG) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Neogen (NEOG) give insight into how the company performed in the quarter ended May 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks Investment Research30/7/2026Neutral

Neogen (NEOG) Beats Q4 Earnings and Revenue Estimates

Neogen (NEOG) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.05 per share a year ago.

MarketBeat30/7/2026Neutral

Neogen Q4 Earnings Call Highlights

Neogen NASDAQ: NEOG reported fiscal fourth-quarter revenue of $225.3 million, with core revenue growth of 4.3%, its highest growth rate of fiscal 2026. The company said momentum improved across both its food safety and animal safety businesses as it entered fiscal 2027, while management outlined increased spending on research and development, commercial capabilities and technology.

GuruFocus30/7/2026Neutral

Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results

NeogenÂ Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced its financial results for the fiscal fourth quarter and full fisca

Evolución del número de empleados de NEOG

Actual

2,636

Cambio

-11.37%

Mínimo

2,108

Máximo

2,974

Presentaciones recientes

Fecha del informe	Empleados	Tipo de formulario	Fecha de presentación	Archivo SEC
31 may 2026	2,636	10-K	30 jul 2026	Ver
31 may 2025	2,974	10-K	30 jul 2025	Ver
31 may 2024	2,917	10-K	30 jul 2024	Ver
31 may 2023	2,640	10-K	15 ago 2023	Ver
31 may 2022	2,108	10-K	27 jul 2022	Ver

Acciones relacionadasMedical - Diagnostics & Research

Ver todas las acciones de EE. UU. →

Sobre nosotrosPolítica de privacidadTérminos de servicioAviso legalDirectorio de accionesETFÍndicesCarteras 13FPrecios objetivoHerramientas gratuitasMapa tecnológicoÚnete a nuestro Slack

Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal

Neogen Corporation